Inpatient Treatment of Community-Acquired Pneumonias with Integrative Medicine

Table 6

Complications in comparison to control group (Pneumonia PORT Validation Cohort [32]) in regard to mortality rate and the necessity to treat patients in ICU.

	Study series	Control group (𝑛=1343)	𝑃 value
Treated on ICU	0/26 (0%)	124/1343 (9.20%)	𝑃=0.10
Mortality study series (𝑛=26)	1/26 (3.8%)	107/1343 (8%)	𝑃=0.44
Mortality with excluded patients (𝑛=48)	3/48 (6.25%)	107/1343 (8%)	𝑃=0.69